{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:17:58Z","timestamp":1769577478794,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,4]]},"DOI":"10.7759\/cureus.75105","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T18:14:51Z","timestamp":1733336091000},"source":"Crossref","is-referenced-by-count":1,"title":["A Rare Presentation of Erythrodermic Psoriasis"],"prefix":"10.7759","author":[{"given":"Kriti","family":"Vaidya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunam","family":"Mukan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Whittam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Erythrodermic psoriasis. Precipitating factors, course, and prognosis in 50 patients","volume":"21","author":"Boyd AS","year":"1989","unstructured":"Boyd AS, Menter A. Erythrodermic psoriasis. Precipitating factors, course, and prognosis in 50 patients. J Am Acad Dermatol. 1989, 21:985-91.","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2011.8","article-title":"The increase in surface CXCR4 expression on lung extravascular neutrophils and its effects on neutrophils during endotoxin-induced lung injury","volume":"8","author":"Yamada M","year":"2011","unstructured":"Yamada M, Kubo H, Kobayashi S, et al.. The increase in surface CXCR4 expression on lung extravascular neutrophils and its effects on neutrophils during endotoxin-induced lung injury. Cell Mol Immunol. 2011, 8:305-14. 10.1038\/cmi.2011.8","journal-title":"Cell Mol Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.05.048","article-title":"Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation","volume":"62","author":"Rosenbach M","year":"2010","unstructured":"Rosenbach M, Hsu S, Korman NJ, Lebwohl MG, Young M, Bebo BF Jr, Van Voorhees AS. Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010, 62:655-62. 10.1016\/j.jaad.2009.05.048","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04679.x","article-title":"Generalized pustular and erythrodermic psoriasis associated with bupropion treatment","volume":"146","author":"Cox NH","year":"2002","unstructured":"Cox NH, Gordon PM, Dodd H. Generalized pustular and erythrodermic psoriasis associated with bupropion treatment. Br J Dermatol. 2002, 146:1061-3. 10.1046\/j.1365-2133.2002.04679.x","journal-title":"Br J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)90180-9","article-title":"Detection of circulating adhesion molecules in erythrodermic skin disease","volume":"32","author":"Groves RW","year":"1995","unstructured":"Groves RW, Kapahi P, Barker JN, Haskard DO, MacDonald D. Detection of circulating adhesion molecules in erythrodermic skin disease. J Am Acad Dermatol. 1995, 32:32-6. 10.1016\/0190-9622(95)90180-9","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2009.09.014","article-title":"Wide-spectrum profile of inflammatory mediators in the plasma and scales of patients with psoriatic disease","volume":"49","author":"Deeva I","year":"2010","unstructured":"Deeva I, Mariani S, De Luca C, et al.. Wide-spectrum profile of inflammatory mediators in the plasma and scales of patients with psoriatic disease. Cytokine. 2010, 49:163-70. 10.1016\/j.cyto.2009.09.014","journal-title":"Cytokine"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-014-1322-0","article-title":"Analysis of Th1\/Th2 response pattern for erythrodermic psoriasis","volume":"34","author":"Zhang P","year":"2014","unstructured":"Zhang P, Chen HX, Duan YQ, Wang WZ, Zhang TZ, Li JW, Tu YT. Analysis of Th1\/Th2 response pattern for erythrodermic psoriasis. J Huazhong Univ Sci Technolog Med Sci. 2014, 34:596-601. 10.1007\/s11596-014-1322-0","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2018.75810","article-title":"Dermatology life quality index and disease coping strategies in psoriasis patients","volume":"36","author":"Liluashvili S","year":"2019","unstructured":"Liluashvili S, Kituashvili T. Dermatology life quality index and disease coping strategies in psoriasis patients. Postepy Dermatol Alergol. 2019, 36:419-24. 10.5114\/ada.2018.75810","journal-title":"Postepy Dermatol Alergol"},{"key":"ref9","article-title":"Plaque psoriasis","author":"Badri T","year":"2023","unstructured":"Badri T, Kumar P, Oakley AM. Plaque psoriasis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.14744\/nci.2016.16023","article-title":"A brief summary of clinical types of psoriasis","volume":"3","author":"Sarac G","year":"2016","unstructured":"Sarac G, Koca TT, Baglan T. A brief summary of clinical types of psoriasis. North Clin Istanb. 2016, 3:79-82. 10.14744\/nci.2016.16023","journal-title":"North Clin Istanb"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01283-2","article-title":"Targeted treatment for erythrodermic psoriasis: rationale and recent advances","volume":"80","author":"Shao S","year":"2020","unstructured":"Shao S, Wang G, Maverakis E, Gudjonsson JE. Targeted treatment for erythrodermic psoriasis: rationale and recent advances. Drugs. 2020, 80:525-34. 10.1007\/s40265-020-01283-2","journal-title":"Drugs"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6364351","article-title":"Psoriasis: genetic associations and immune system changes","volume":"8","author":"Liu Y","year":"2007","unstructured":"Liu Y, Krueger JG, Bowcock AM. Psoriasis: genetic associations and immune system changes. Genes Immun. 2007, 8:1-12. 10.1038\/sj.gene.6364351","journal-title":"Genes Immun"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X20143762","article-title":"Psoriasis severity and hypothalamic-pituitary-adrenal axis function: results from the CALIPSO study","volume":"47","author":"Brunoni AR","year":"2014","unstructured":"Brunoni AR, Santos IS, Sabbag C, Lotufo PA, Bense\u00f1or IM. Psoriasis severity and hypothalamic-pituitary-adrenal axis function: results from the CALIPSO study. Braz J Med Biol Res. 2014, 47:1102-6. 10.1590\/1414-431X20143762","journal-title":"Braz J Med Biol Res"},{"key":"ref14","article-title":"The wisdom of the body","author":"Cannon WB","year":"1932","unstructured":"Cannon WB. The wisdom of the body. W. W. Norton & Company, Inc., New York; 1932."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2009.03410.x","article-title":"A comprehensive review of biomarkers in psoriasis","volume":"34","author":"Rashmi R","year":"2009","unstructured":"Rashmi R, Rao KS, Basavaraj KH. A comprehensive review of biomarkers in psoriasis. Clin Exp Dermatol. 2009, 34:658-63. 10.1111\/j.1365-2230.2009.03410.x","journal-title":"Clin Exp Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020498","article-title":"Orchestrated cytokines mediated by biologics in psoriasis and its mechanisms of action","volume":"10","author":"Mohd Noor AA","year":"2022","unstructured":"Mohd Noor AA, Azlan M, Mohd Redzwan N. Orchestrated cytokines mediated by biologics in psoriasis and its mechanisms of action. Biomedicines. 2022, 10:498. 10.3390\/biomedicines10020498","journal-title":"Biomedicines"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.137.1.53","article-title":"Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders","volume":"137","author":"Garg A","year":"2001","unstructured":"Garg A, Chren MM, Sands LP, Matsui MS, Marenus KD, Feingold KR, Elias PM. Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol. 2001, 137:53-9. 10.1001\/archderm.137.1.53","journal-title":"Arch Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00802-1","article-title":"Mindfulness and meditation for psoriasis: a systematic review","volume":"12","author":"Bartholomew E","year":"2022","unstructured":"Bartholomew E, Chung M, Yeroushalmi S, Hakimi M, Bhutani T, Liao W. Mindfulness and meditation for psoriasis: a systematic review. Dermatol Ther (Heidelb). 2022, 12:2273-83. 10.1007\/s13555-022-00802-1","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref19","article-title":"Drug focus: adalimumab in the treatment of moderate to severe psoriasis","volume":"1","author":"Vena GA","year":"2007","unstructured":"Vena GA, Cassano N. Drug focus: adalimumab in the treatment of moderate to severe psoriasis. Biologics. 2007, 1:93-103.","journal-title":"Biologics"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2147\/tcrm.s1265","article-title":"Treating psoriasis with adalimumab","volume":"4","author":"Alwawi EA","year":"2008","unstructured":"Alwawi EA, Mehlis SL, Gordon KB. Treating psoriasis with adalimumab. Ther Clin Risk Manag. 2008, 4:345-51. 10.2147\/tcrm.s1265","journal-title":"Ther Clin Risk Manag"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/251135-a-rare-presentation-of-erythrodermic-psoriasis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T18:14:53Z","timestamp":1733336093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/251135-a-rare-presentation-of-erythrodermic-psoriasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.75105","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,4]]}}}